Compare Sumber Mineral Global Abadi Tbk. (SMGA) vs Tempo Scan Pacific Tbk. (TSPC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sumber Mineral Global Abadi Tbk. vs Tempo Scan Pacific Tbk. — how do they compare? Sumber Mineral Global Abadi Tbk. trades at Rp76 (market cap 638.75B, 21.58M 24h volume), while Tempo Scan Pacific Tbk. trades at Rp2,580 (market cap 11.68T, 429.7K 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 18.3× Sumber Mineral Global Abadi Tbk.'s market cap, and Sumber Mineral Global Abadi Tbk. is more actively traded (21.58M versus 429.7K). Which is the better fit depends on your goals.
| SMGA | TSPC | |
|---|---|---|
Market Cap | 638.75B | 11.68T |
Volume | 21.58M | 429.7K |
Lot | 215.82K | 4.3K |
Turnover | 1.58B | 1.11B |
Average Price | 73.21 | 2,591.65 |
Value | 1.58B | 1.11B |
Indicative Equilibrium Price | 76 | 2,580 |
Indicative Equilibrium Volume | 12.3K | 100 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sumber Mineral Global Abadi Tbk.
PT Sumber Mineral Global Abadi Tbk (the Company) was established based on Notarial Deed No. 2 dated October 19, 2016 of Selina Bertha Eny, S.H., a notary in South Tanggerang. The Company started its commercial operations in 2016. The Company’s immediate and ultimate parententities are PT Sumber Global Energy Tbk and PT Sumbermas Inti Energi, respectively, both entities domiciled in Jakarta. The controlling interest of the Company is PT Sumber Global Energy Tbk.
Read more on SMGA →About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →
